Core Viewpoint - Huaxi Biological announced an expected net profit of 270 million to 320 million yuan for 2025, representing a year-on-year increase of 54.93% to 83.63%, driven by systematic transformation rather than short-term scale expansion [1] Group 1: Financial Performance - The company anticipates a net profit attributable to shareholders of 270 million to 320 million yuan for 2025, with a year-on-year growth of 54.93% to 83.63% [1] - The net profit after deducting non-recurring gains and losses is expected to be between 167 million and 217 million yuan, reflecting a year-on-year increase of 55.68% to 102.29% [1] - Management expenses are projected to decrease by over 10% year-on-year in 2025, contributing to profit growth through effective cost control [1] Group 2: Strategic Transformation - The core driver of the performance growth is the company's strategic shift from "scale-oriented" to "quality-oriented" and "efficiency-oriented" operations [1] - Huaxi Biological is optimizing its organizational structure by integrating overlapping functions and promoting a flatter, more agile management approach to enhance decision-making efficiency [1] Group 3: Business Operations - The company is focusing on professional development and continuously optimizing its business structure and resource allocation [2] - Sales expenses are expected to decrease by over 30% year-on-year in 2025, indicating improved profitability despite revenue pressures [1] Group 4: Research and Innovation - Huaxi Biological is enhancing its research capabilities by focusing on the role of carbohydrates in cell differentiation and signaling mechanisms, with a strong emphasis on core areas such as extracellular matrix and intercellular communication [2] - The company is integrating artificial intelligence into various business scenarios, including R&D, manufacturing, supply chain management, and financial operations, to improve operational efficiency [2] Group 5: Long-term Vision - The anticipated growth in 2025 is a result of the company's organizational optimization, business focus, technological innovation, and digital empowerment [2] - Huaxi Biological aims to continue prioritizing technological innovation and synthetic biology technology to strengthen its long-term competitive advantage and sustainable development capabilities [2]